These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2731433)

  • 1. Mechanisms in myeloid tumorigenesis 1988. Workshop at the National Cancer Institute, National Institutes of Health. Bethesda, MD, USA, March 22, 1988. Proceedings.
    Curr Top Microbiol Immunol; 1989; 149():1-172. PubMed ID: 2731433
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms in B-cell neoplasia. Workshop at the National Cancer Institute, National Institutes of Health, Bethesda, MD, USA, March 23-25, 1988. Proceedings.
    Curr Top Microbiol Immunol; 1988; 141():1-340. PubMed ID: 3265084
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms in B-cell neoplasia. Workshop at the National Cancer Institute, National Institutes of Health. Bethesda, MD, USA, March 24-26, 1986.
    Curr Top Microbiol Immunol; 1986; 132():1-374. PubMed ID: 3491730
    [No Abstract]   [Full Text] [Related]  

  • 4. Oncogenes in B-cell neoplasia. Workshop at the National Cancer Institute, National Institutes of Health, Bethesda, MD, USA, March 5-7,1984.
    Curr Top Microbiol Immunol; 1984; 113():1-268. PubMed ID: 6332708
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital urinary tract obstruction: Proceedings of the State-Of-The-Art Strategic Planning Workshop-National Institutes of Health, Bethesda, Maryland, USA, 11-12 March 2002.
    Chevalier RL; Peters CA
    Pediatr Nephrol; 2003 Jun; 18(6):576-606. PubMed ID: 12720078
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings of the 4th Inter-Institute Workshop on Optical Imaging from Bench to Bedside at the National Institutes of Health, Bethesda, Maryland, USA.
    J Biomed Opt; 2005; 10(5):051301-051802. PubMed ID: 16292937
    [No Abstract]   [Full Text] [Related]  

  • 7. Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.
    Griffith LM; Pavletic SZ; Tyndall A; Bredeson CN; Bowen JD; Childs RW; Gratwohl A; van Laar JM; Mayes MD; Martin R; McSweeney PA; Muraro PA; Openshaw H; Saccardi R; Sandmaier BM; Forman SJ; Nash RA;
    Biol Blood Marrow Transplant; 2005 Nov; 11(11):862-70. PubMed ID: 16275589
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible mechanisms of pathogenesis and acute transformation in chronic myeloid leukemia.
    Pedersen B
    Ser Haematol; 1975; 8(4):45-52. PubMed ID: 798285
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitamin D and cancer. Proceedings of the vitamin D workshop meeting. November 17-19, 2004. National Institutes of Health, Bethesda, Maryland, USA.
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):1-218. PubMed ID: 16242930
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic myeloid leukemia following radiotherapy for breast cancer.
    Berrebi A; Estrov Z; Chemke J
    Isr J Med Sci; 1983 Jul; 19(7):653-4. PubMed ID: 6576990
    [No Abstract]   [Full Text] [Related]  

  • 11. Ocular tissue culture. Proceedings of a symposium sponsored by the National Eye Institute, National Institutes of Health, Bethesda, MD, 22-23 October, 1979.
    Vision Res; 1981; 21(1):1-174. PubMed ID: 7269276
    [No Abstract]   [Full Text] [Related]  

  • 12. HOX genes: not just myeloid oncogenes any more.
    Lawrence HJ; Fischbach NA; Largman C
    Leukemia; 2005 Aug; 19(8):1328-30. PubMed ID: 15931267
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathogenesis of chronic myeloid leukemia].
    Bottura C
    Rev Hosp Clin Fac Med Sao Paulo; 1978 Feb; 33(1):52-6. PubMed ID: 276015
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy-related myeloid neoplasms].
    Harada Y; Harada H
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():699-703. PubMed ID: 23134031
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigens of human melanoma as defined by monoclonal antibodies. Second workshop on monoclonal antibodies to melanoma. National Institutes of Health, National Cancer Institute, Bethesda, Maryland, USA, April 26-27, 1982.
    Hybridoma; 1982; 1(4):379-482. PubMed ID: 6926854
    [No Abstract]   [Full Text] [Related]  

  • 16. [Advances concerning the pathogenesis of leukemia].
    Neuwirt J
    Vnitr Lek; 1980 Nov; 26(11):1041-6. PubMed ID: 6942589
    [No Abstract]   [Full Text] [Related]  

  • 17. Insertional mutagenesis identifies cooperation between Setbp1 and Mllt3 in inducing myeloid leukemia development.
    Vishwakarma BA; Gudmundsson KO; Oakley K; Han Y; Du Y
    Leukemia; 2019 Aug; 33(8):2121-2125. PubMed ID: 30894666
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute myeloid leukemia: something more than a simple molecular defect.
    Roman J; Torres A
    Haematologica; 2002 Jun; 87(6):562-3. PubMed ID: 12031909
    [No Abstract]   [Full Text] [Related]  

  • 19. Myeloid leukemia after cytotoxic therapy and other hematotoxins.
    Larson RA
    J Toxicol Environ Health A; 2000 Nov; 61(5-6):381-6. PubMed ID: 11086943
    [No Abstract]   [Full Text] [Related]  

  • 20. Telomere length and hTERT expression in patients with acute myeloid leukemia correlate with karyotypic instability.
    Engelhardt M; Wäsch R
    Haematologica; 2005 Mar; 90(3):289B. PubMed ID: 15749652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.